Back to search
Central Retinal Vein Occlusion With Macular Edema
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Central Retinal Vein Occlusion With Macular Edema trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Central Retinal Vein Occlusion With Macular Edema trials you may qualify forRetinal vein occlusion (RVO), a common retinal vascular disease, is frequently treated with anti-vascular endothelial growth factor (anti-VEGF) agents as first-…
EYE-RES-104 is a randomized, dose-masked study of intravitreal EYE103 in participants with neovascular age-related macular degeneration (NVAMD) or macular edema…
Intravitreal injections of Ranibizumab will be applied in all patients according to treatment guidelines. The experimental group will receive additional targete…
This is a open label, multicenter, Phase II study to evaluate the usability of the pre-filled syringe (PFS) of SB11 (ranibizumab biosimilar). Healthcare Profess…
The study will compare the safety of ophthalmic bevacizumab in vials versus pre-filled syringes in subjects diagnosed with a retinal condition that would benefi…